Join us for Breakfast at King's hosted by Prof. James Galloway, a video series featuring updates in rheumatology with experts at King's College London. In this episode, Dr Andrew Rutherford discusses the management of patients with rheumatoid arthritis and antidrug antibodies, who are being treated with biologics, including which biologic drugs have the highest risk of antidrug antibodies and whether methotrexate can reduce this risk.